Literature DB >> 11164377

[(3)H]ZM241385--an antagonist radioligand for adenosine A(2A) receptors in rat brain.

S P Alexander1, P J Millns.   

Abstract

Binding of the novel adenosine A(2A) receptor-selective antagonist radioligand [2-(3)H]-4-(2-[7-amino-2-(2-furyl)(1,2,4)triazolo(2,3-a)(1,3,5,)triazin-5-yl amino]ethyl)phenol ([(3)H]ZM241385) was examined using particulate preparations and frozen sections of rat brain. In membranes from the rat striatum, binding was saturable, reversible and temperature-dependent. Analysis of saturation isotherms indicated that [(3)H]ZM241385 bound with high affinity (K(d) of 0.84 nM), high density (1680 fmol mg protein(-1)) and with a high proportion of specific binding (93% at 1 nM radioligand). Examination of competition profiles indicated that [(3)H]ZM241385 bound to sites with an A(2A) adenosine receptor-like rank order. The presence of guanosine 5'-(3-thio)-triphosphate failed to alter either [(3)H]ZM241385 binding or agonist competition for [(3)H]ZM241385 binding. Autoradiographic analysis of [(3)H]ZM241385 binding to frozen sections of rat brain indicated specific binding to the rat striatum of similar affinity (K(d) of 0.43 nM) and susceptibility to adenosine receptor ligands. At 2 nM [(3)H]ZM241385, specific binding comprised 95+/-1% total binding. In the hippocampus and frontal cortex, binding of [(3)H]ZM241385 failed to saturate and was of lower density. Taken together, these results indicate that [(3)H]ZM241385 should prove to be a useful radioligand in the characterisation of adenosine A(2A) receptors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11164377     DOI: 10.1016/s0014-2999(00)00899-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

Review 1.  Recent developments in adenosine receptor ligands and their potential as novel drugs.

Authors:  Christa E Müller; Kenneth A Jacobson
Journal:  Biochim Biophys Acta       Date:  2010-12-23

2.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

3.  Loss of constitutive activity is correlated with increased thermostability of the human adenosine A2A receptor.

Authors:  Nicolas Bertheleme; Shweta Singh; Simon J Dowell; Julia Hubbard; Bernadette Byrne
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

4.  Endogenous expression of adenosine A1, A2 and A3 receptors in rat C6 glioma cells.

Authors:  Carlos Alberto Castillo; José Luís Albasanz; Mercedes Fernández; Mairena Martín
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 4.414

5.  Mass spectrometry-based ligand binding assays on adenosine A1 and A2A receptors.

Authors:  A Massink; M Holzheimer; A Hölscher; J Louvel; D Guo; G Spijksma; T Hankemeier; A P IJzerman
Journal:  Purinergic Signal       Date:  2015-10-19       Impact factor: 3.765

Review 6.  Molecular probes for the human adenosine receptors.

Authors:  Xue Yang; Laura H Heitman; Adriaan P IJzerman; Daan van der Es
Journal:  Purinergic Signal       Date:  2020-12-12       Impact factor: 3.765

Review 7.  Allosteric Interactions between Adenosine A2A and Dopamine D2 Receptors in Heteromeric Complexes: Biochemical and Pharmacological Characteristics, and Opportunities for PET Imaging.

Authors:  Kavya Prasad; Erik F J de Vries; Philip H Elsinga; Rudi A J O Dierckx; Aren van Waarde
Journal:  Int J Mol Sci       Date:  2021-02-09       Impact factor: 5.923

8.  Structural and energetic effects of A2A adenosine receptor mutations on agonist and antagonist binding.

Authors:  Henrik Keränen; Hugo Gutiérrez-de-Terán; Johan Åqvist
Journal:  PLoS One       Date:  2014-10-06       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.